Cargando…
Quantification of the virus-host interaction in human T lymphotropic virus I infection
BACKGROUND: HTLV-I causes the disabling inflammatory disease HAM/TSP: there is no vaccine, no satisfactory treatment and no means of assessing the risk of disease or prognosis in infected people. Like many immunopathological diseases with a viral etiology the outcome of infection is thought to depen...
Autores principales: | Asquith, Becca, Mosley, Angelina J, Heaps, Adrian, Tanaka, Yuetsu, Taylor, Graham P, McLean, Angela R, Bangham, Charles RM |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1327681/ https://www.ncbi.nlm.nih.gov/pubmed/16336683 http://dx.doi.org/10.1186/1742-4690-2-75 |
Ejemplares similares
-
Human T-Lymphotropic Virus-1 Visualized at the Virological Synapse by Electron Tomography
por: Majorovits, Endre, et al.
Publicado: (2008) -
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial
por: Taylor, Graham P, et al.
Publicado: (2006) -
Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
por: Gillet, Nicolas A., et al.
Publicado: (2013) -
High frequency of CD4(+)FoxP3(+) cells in HTLV-1 infection: inverse correlation with HTLV-1–specific CTL response
por: Toulza, Frederic, et al.
Publicado: (2008) -
CD8 malignant proliferation in association with human T cell lymphotropic Virus 1 infection: a case report
por: Kagdi, Huseini, et al.
Publicado: (2015)